Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rockwell Medical (RMTI) Liabilities and Shareholders Equity (2016 - 2025)

Rockwell Medical (RMTI) has disclosed Liabilities and Shareholders Equity for 16 consecutive years, with $57.5 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Liabilities and Shareholders Equity rose 0.7% year-over-year to $57.5 million, compared with a TTM value of $223.3 million through Sep 2025, up 4.82%, and an annual FY2024 reading of $59.2 million, up 13.48% over the prior year.
  • Liabilities and Shareholders Equity was $57.5 million for Q3 2025 at Rockwell Medical, up from $52.6 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $69.4 million in Q1 2021 and bottomed at $37.4 million in Q1 2022.
  • Average Liabilities and Shareholders Equity over 5 years is $52.9 million, with a median of $53.0 million recorded in 2024.
  • The sharpest move saw Liabilities and Shareholders Equity crashed 46.1% in 2022, then surged 39.41% in 2024.
  • Year by year, Liabilities and Shareholders Equity stood at $48.6 million in 2021, then decreased by 3.99% to $46.6 million in 2022, then rose by 11.88% to $52.2 million in 2023, then grew by 13.48% to $59.2 million in 2024, then decreased by 2.91% to $57.5 million in 2025.
  • Business Quant data shows Liabilities and Shareholders Equity for RMTI at $57.5 million in Q3 2025, $52.6 million in Q2 2025, and $54.0 million in Q1 2025.